COVID-19 breakthrough infection after inactivated vaccine induced robust antibody responses and cross-neutralization of SARS-CoV-2 variants, but less immunity against omicron

Nungruthai Suntronwong, Ritthideach Yorsaeng, Jiratchaya Puenpa, Chompoonut Auphimai, Thanunrat Thongmee, Preeyaporn Vichaiwattana, Sitthichai Kanokudom, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Suvichada Assawakosri, Pornjarim Nilyanimit, Sirapa Klinfueng, Lakkhana Wongsrisang, Donchida Srimuan, Thaksaporn Thatsanatorn, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan
doi: https://doi.org/10.1101/2022.01.17.22269415

Article Information

doi 
https://doi.org/10.1101/2022.01.17.22269415
History 
  • January 18, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Nungruthai Suntronwonga,
  2. Ritthideach Yorsaenga,
  3. Jiratchaya Puenpaa,
  4. Chompoonut Auphimaia,
  5. Thanunrat Thongmeea,
  6. Preeyaporn Vichaiwattanaa,
  7. Sitthichai Kanokudoma,
  8. Thaneeya Duangchindab,
  9. Warangkana Chantimac,d,
  10. Pattarakul Pakchotanonb,
  11. Suvichada Assawakosria,
  12. Pornjarim Nilyanimita,
  13. Sirapa Klinfuenga,
  14. Lakkhana Wongsrisanga,
  15. Donchida Srimuana,
  16. Thaksaporn Thatsanatorna,
  17. Natthinee Sudhinaraseta,
  18. Nasamon Wanlapakorna and
  19. Yong Poovorawana,e,*
  1. aCenter of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
  2. bMolecular Biology of Dengue and Flaviviruses Research Team, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Development Agency, NSTDA, Pathum Thani 12120, Thailand
  3. cDivision of Dengue Hemorrhagic Fever Research, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
  4. dSiriraj Center of Research Excellence in Dengue and Emerging Pathogens, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
  5. eRoyal Society of Thailand (FRS(T)), Sanam Sueapa, Dusit, Bangkok 10330, Thailand
  1. ↵*Corresponding author: Yong Poovorawan, MD, Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand, Email: yong.p{at}chula.ac.th
Back to top
Posted January 18, 2022.
Download PDF

Supplementary Material

Data/Code
Email
COVID-19 breakthrough infection after inactivated vaccine induced robust antibody responses and cross-neutralization of SARS-CoV-2 variants, but less immunity against omicron
Nungruthai Suntronwong, Ritthideach Yorsaeng, Jiratchaya Puenpa, Chompoonut Auphimai, Thanunrat Thongmee, Preeyaporn Vichaiwattana, Sitthichai Kanokudom, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Suvichada Assawakosri, Pornjarim Nilyanimit, Sirapa Klinfueng, Lakkhana Wongsrisang, Donchida Srimuan, Thaksaporn Thatsanatorn, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Yong Poovorawan
medRxiv 2022.01.17.22269415; doi: https://doi.org/10.1101/2022.01.17.22269415
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area